Table 1 Stakeholder participation in the 2009 and 2011 public consultations on revision of the Clinical Trials Directive
From: Input analysis for two public consultations on the EU Clinical Trials Regulation
Public consultation 2009 | Public consultation 2011 | |||||||
|---|---|---|---|---|---|---|---|---|
N | Exclusiona | Eligible for analysis | Included in sample | N | Exclusiona | Eligible for analysis | Included in sample | |
Non-profit | 32 | 3 (P, F, F) | 29 | 10 | 36 | 2 (P, P) | 34 | 11 |
Industry | 21 | 2 (P, P) | 19 | 6 | 35 | 3 (P, P, F) | 32 | 11 |
Medical societies | 20 | – | 20 | 7 | 16 | – | 16 | 5 |
Authorities | 12 | – | 12 | 4 | 18 | 1 (P) | 17 | 6 |
Individuals | 8 | 1 (P) | 7 | 2 | 9 | – | 9 | 3 |
Research ethics Committees | 5 | 2 (L, L) | 3 | 1 | 6 | 2 (L, L) | 4 | 1 |
Patient organizations | 3 | – | 3 | 1 | 12 | – | 12 | 4 |
Other | 5 | 1 (P) | 4 | 1 | 12 | 1 (F) | 11 | 4 |
Total | 106 | 9 | 97 | 32 | 144 | 9 | 135 | 45 |